Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Aug 11, 2020 2:13am
242 Views
Post# 31391095

Spectral Analytics really want to make Donald Trump happy!

Spectral Analytics really want to make Donald Trump happy!I just watched webinar video 2nd time which got me little more excited. You need to watch Spectral Analytics people again. They are talking to White House to make FDA process little faster. https://questcapinc.com/corporate-update-investor-webinar-august-2020/

I think, here is why, they are pushing it

Donald Trump wants some sort of vaccine or drug to cure Covid-19 before the election in November. None of other vaccine going to ready before election, but Spectral Analytics can make it happen before the election.
  1. Spectral Analytics already done two IN VITRO studies and submitted on July 27, 2020
  2. Spectral Analytics using two (2) FDA approved drugs which will be repurposed as a COVID19 treatment as they were able to lower the viral load.
  3. They do not need to study for side effects, which is lot of work as these drugs are already FDA approved and side effect study already done.
  4. They already filed for patent worldwide.
  5. Spectral has already received Institutional Review Board (IRB) approval for the clinical study and the principal investigator for the first phase 1 clinical study has been initiated.
  6. Clinical site ready go upon FDA approval.
  7. First clinical trial for treating Covid-19 patient should be done in 30 days plus 7 day getting all the data.
  8. Worldwide distribution already worked out with generic drug manufacturer.
  9. Potential to run trial in third country which should be even quicker.
If you put all the time needed for this trial, it can be ready before election

https://www.wfmj.com/story/42414020/spectral-analytics-announces-positive-results-in-vitro-research-for-the-upcoming-patient-trial-for-covid-19-treatment

<< Previous
Bullboard Posts
Next >>